Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,263 across all filing types
Latest filing 2022-04-13 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements, specifically Regulation 39(3), which pertains to share certificate loss and reissuance. The content is an announcement about a shareholder's lost share certificates and the company's intention to issue duplicates upon completion of formalities. There are no financial statements, earnings data, management discussion, or report attachments. The document is short (1703 characters) and serves as a regulatory announcement related to shareholding records rather than a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-04-13 English
General updates
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agents (RTA) confirming compliance with dematerialization regulations for the period 01.03.2022 to 31.03.2022. It is addressed to stock exchanges and signed by the company secretary. The document is short (3192 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance filing related to securities dematerialization and transfer agent confirmation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and certifications that do not fit other specific categories.
2022-04-12 English
We are enclosing herewith Certificate dated April 11, 2022 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agents confirming compliance with dematerialization regulations for the period 01.03.2022 to 31.03.2022. It is addressed to stock exchanges and signed by the company secretary. The document is short (3192 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance filing related to securities dematerialization and registrar activities. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and certifications that do not fit other specific categories.
2022-04-12 English
This is to certify that, Integrated Registry Management Services Private Limited are the Company's Registrar and Transfer Agents and that all activities in relation to the share transfer ....
Regulatory Filings Classification · 95% confidence The document consists of certificates under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, issued by the company and its Registrar and Transfer Agents. It certifies that share transfer activities are maintained by the Registrar and Transfer Agents. The document is a formal certification letter addressed to stock exchanges, confirming compliance with regulatory requirements related to share transfer agents. It does not contain financial statements, management discussion, or any report data. The document length is 3480 characters, which is relatively short and is a certification letter rather than a report or announcement of a report. According to the classification rules, such certification letters fall under Regulatory Filings (RNS).
2022-04-12 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of share certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 39(3). The content is about notifying the exchanges of a shareholder's lost share certificates and does not contain financial data, management discussion, or report publication. It is an official regulatory communication related to shareholding records but not a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-04-05 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and related disclosures. The content is about notifying the exchanges of the loss of specific share certificates and does not contain financial data, management discussion, voting results, or any report publication. It is a regulatory notification related to shareholding records but does not fit into categories like Major Shareholding Notification (MRQ) since it does not indicate a change in ownership levels, nor is it a Director's Dealing (DIRS) or Share Issue/Capital Change (SHA). Given the nature of the document as a compliance notification to the stock exchanges about lost share certificates, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories. The document length is short (1574 characters), and it is not an announcement of a report but a direct notification.
2022-04-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.